PRICE T ROWE ASSOCIATES INC /MD/ - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 53 filers reported holding ENZO BIOCHEM INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$63
-24.1%
44,8000.0%0.00%
Q2 2023$83
-23.9%
44,8000.0%0.00%
Q1 2023$109
+70.3%
44,8000.0%0.00%
Q4 2022$64
-99.9%
44,8000.0%0.00%
Q3 2022$100,000
+7.5%
44,8000.0%0.00%
Q2 2022$93,000
-28.5%
44,8000.0%0.00%
Q1 2022$130,000
-9.7%
44,8000.0%0.00%
Q4 2021$144,000
-9.4%
44,8000.0%0.00%
Q3 2021$159,000
+12.0%
44,8000.0%0.00%
Q2 2021$142,000
-26.8%
44,800
-20.5%
0.00%
Q1 2021$194,000
-18.5%
56,363
-40.2%
0.00%
Q4 2020$238,000
+19.6%
94,2810.0%0.00%
Q3 2020$199,000
+40.1%
94,281
+49.0%
0.00%
Q2 2020$142,000
+264.1%
63,281
+311.4%
0.00%
Q1 2020$39,000
-2.5%
15,3800.0%0.00%
Q4 2019$40,000
-18.4%
15,380
+12.8%
0.00%
Q3 2019$49,000
+8.9%
13,631
+1.4%
0.00%
Q2 2019$45,000
+25.0%
13,443
+0.7%
0.00%
Q1 2019$36,000
-2.7%
13,343
+0.8%
0.00%
Q4 2018$37,000
-32.7%
13,243
-0.7%
0.00%
Q3 2018$55,000
-20.3%
13,3430.0%0.00%
Q2 2018$69,000
-5.5%
13,343
+0.4%
0.00%
Q1 2018$73,000
-32.4%
13,289
+0.6%
0.00%
Q4 2017$108,000
-21.7%
13,2090.0%0.00%
Q3 2017$138,000
-5.5%
13,2090.0%0.00%
Q2 2017$146,000
+31.5%
13,2090.0%0.00%
Q1 2017$111,000
+20.7%
13,209
-0.3%
0.00%
Q4 2016$92,000
+37.3%
13,2550.0%0.00%
Q3 2016$67,000
-14.1%
13,255
+1.2%
0.00%
Q2 2016$78,000
+30.0%
13,1000.0%0.00%
Q1 2016$60,000
+1.7%
13,1000.0%0.00%
Q4 2015$59,000
+40.5%
13,1000.0%0.00%
Q3 2015$42,000
+5.0%
13,1000.0%0.00%
Q2 2015$40,000
+2.6%
13,1000.0%0.00%
Q1 2015$39,000
-32.8%
13,1000.0%0.00%
Q4 2014$58,000
-13.4%
13,1000.0%0.00%
Q3 2014$67,000
-2.9%
13,1000.0%0.00%
Q2 2014$69,000
+27.8%
13,1000.0%0.00%
Q1 2014$54,000
-28.9%
13,100
-50.0%
0.00%
Q4 2013$76,000
+130.3%
26,200
+100.0%
0.00%
Q3 2013$33,000
-38.9%
13,100
-50.0%
0.00%
Q2 2013$54,00026,2000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders